infliximab-dyyb
FDA Approves Zymfentra for IBD
The FDA approved Zymfentra for the treatment of inflammatory bowel disease.
OCTOBER 27, 2023
Bucking Trend, Kaiser Boosts Biosimilar Uptake
Adoption of infliximab biosimilars has been negligible across the United States, but Kaiser Permanente Northwest ...
FEBRUARY 14, 2019
Load more